Overview
Zia Khan is a Pathologist practicing medicine in Brooklyn, New York.
His clinical expertise encompasses Opioid Use Disorder.
He is actively involved in clinical research, co-authoring 2 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- PPO
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2990 Brighton 12th St, Brooklyn, NY 11235
5209 Euclid Ave, Cleveland,, OH 44103
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Presbyterian Hospital And Vanderbilt Clinic
Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. Dr. Gru is highly rated in 32 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Erythroderma, and Tissue Biopsy. Dr. Gru is board certified in Anatomic Pathology, Dermatopathology, and Hematopathology.
Hackensack Meridian Mountainside Medical Center
Adnan Savera is a Pathologist practicing medicine in Montclair, New Jersey. Dr. Savera is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Urothelial Cancer.
Minkowitz Pathology
Gerald Minkowitz is a Pathologist practicing medicine in Brooklyn, New York. Dr. Minkowitz is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Papillary Thyroid Cancer, Aseptic and Alopecic Nodules of Scalp (AANS), Thyroid Cancer, and Hashimoto Thyroiditis.
Frequently Asked Questions about Dr. Zia Khan
How do I make an appointment with Dr. Zia Khan?
You can book an appointment with Dr. Zia Khan by calling their office at 718-743-5159. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Zia Khan a top-rated expert for Opioid Use Disorder?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Zia Khan is classified as an Experienced expert for Opioid Use Disorder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Zia Khan specialize in?
While Dr. Zia Khan is a Pathology, they have specific expertise in Opioid Use Disorder. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pathology.
Does Dr. Zia Khan participate in research or clinical trials?
Yes. Dr. Zia Khan has published 2 articles and abstracts on conditions like Opioid Use Disorder. You can view a list of Dr. Zia Khan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Zia Khan accept my insurance?
Dr. Zia Khan accepts most major insurance plans, including Anthem BCBS and Capital District Physicians Health. We recommend calling the office directly at 718-743-5159 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers